Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia

Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia

Only half of patients with relapsed B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) currently survive with standard treatment protocols. Predicting individual patient responses to defined drugs prior to application would help therapy stratification and could improve survival. With the purp...

Full description

Bibliographic Details
Main Authors:	Anton Gauert, Nadine Olk, Helia Pimentel-Gutiérrez, Kathy Astrahantseff, Lasse D. Jensen, Yihai Cao, Angelika Eggert, Cornelia Eckert, Anja I.H. Hagemann
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	Cancers
Subjects:	pediatric cancer personalized therapy BCP-ALL zebrafish patient-derived xenograft
Online Access:	https://www.mdpi.com/2072-6694/12/7/1883

Similar Items

Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo
by: Dorothee Winterberg, et al.
Published: (2021-06-01)

Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement
by: Emma Kroeze, et al.
Published: (2022-08-01)

DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
by: Magnus Borssén, et al.
Published: (2018-03-01)

Multi-Faceted Effects of ST6Gal1 Expression on Precursor B-Lineage Acute Lymphoblastic Leukemia
by: Mingfeng Zhang, et al.
Published: (2022-03-01)

Added value of molecular karyotype in childhood acute lymphoblastic leukemia
by: Margaux Camuset, et al.
Published: (2023-12-01)

Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia
by: Marco Severgnini, et al.
Published: (2022-07-01)

The role of microenvironment in the initiation and evolution of B-cell precursor acute lymphoblastic leukemia
by: Alicia Garcia-Gimenez, et al.
Published: (2023-03-01)

Circulating Biomarkers Associated with the Diagnosis and Prognosis of B-Cell Progenitor Acute Lymphoblastic Leukemia
by: Claudia Daniela Álvarez-Zúñiga, et al.
Published: (2023-08-01)

Neurofibromatosis Symptom-Lacking B-Cell Lineage Acute Lymphoblastic Leukemia with Only an <i>NF1</i> Gene Pathogenic Variant
by: Zehwan Kim, et al.
Published: (2023-04-01)

Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia
by: Alva Rani James, et al.
Published: (2019-01-01)

miR-582 Suppresses the Proliferation of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells and Protects Them From Natural Killer Cell-Mediated Cytotoxicity
by: Xinxin Li, et al.
Published: (2022-04-01)

Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations
by: Jeremy D. Rubinstein, et al.
Published: (2023-08-01)

High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors
by: Lenka Besse, et al.
Published: (2021-10-01)

RAG1 co‐expression signature identifies ETV6‐RUNX1‐like B‐cell precursor acute lymphoblastic leukemia in children
by: Dongfeng Chen, et al.
Published: (2021-06-01)

Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?
by: Gabriel Levy, et al.
Published: (2022-05-01)

Analysis of non-alcoholic fatty liver disease during induction therapy for B-cell precursor acute lymphoblastic leukemia in children and adolescents
by: Hirozumi Sano, et al.
Published: (2024-01-01)

Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer
by: Saskia Kowald, et al.
Published: (2023-02-01)

Tackling Acute Lymphoblastic Leukemia—One Fish at a Time
by: Arpan A. Sinha, et al.
Published: (2019-10-01)

Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
by: Zhiwu Jiang, et al.
Published: (2016-09-01)

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
by: Federica Tonon, et al.
Published: (2021-08-01)

Single-Cell Transcriptome Analysis Identifies Ligand–Receptor Pairs Associated With BCP-ALL Prognosis
by: Liang Wu, et al.
Published: (2021-03-01)

Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231
by: Jerry Xiao, et al.
Published: (2022-05-01)

Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer
by: Zaheer Ali, et al.
Published: (2022-02-01)

Macrophages enhance Vegfa-driven angiogenesis in an embryonic zebrafish tumour xenograft model
by: Denver D. Britto, et al.
Published: (2018-12-01)

Coagulation FXIII-A Protein Expression Defines Three Novel Sub-populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized by Distinct Gene Expression Signatures
by: Katalin Gyurina, et al.
Published: (2019-10-01)

Perancangan Business Continuity Plan dan Disaster Recovery Plan Teknologi dan Sistem Informasi Menggunakan ISO 22301
by: Ito Setiawan, et al.
Published: (2019-08-01)

Conformational Flexibility of Proteins Involved in Ribosome Biogenesis: Investigations via Small Angle X-ray Scattering (SAXS)
by: Dritan Siliqi, et al.
Published: (2018-02-01)

Generation of a Zebrafish Knock-In Model Recapitulating Childhood ETV6::RUNX1-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
by: Veronika Zapilko, et al.
Published: (2023-12-01)

Blinatumomab Prior to CAR-T Cell Therapy—A Treatment Option Worth Consideration for High Disease Burden
by: Paweł Marschollek, et al.
Published: (2022-11-01)

Case Report: Molecular autopsy underlie COVID-19-associated sudden, unexplained child mortality
by: Kana Unuma, et al.
Published: (2023-04-01)

Modeling Cancer Using Zebrafish Xenografts: Drawbacks for Mimicking the Human Microenvironment
by: Pablo Cabezas-Sáinz, et al.
Published: (2020-08-01)

One Host-Multiple Applications: Zebrafish (<i>Danio rerio</i>) as Promising Model for Studying Human Cancers and Pathogenic Diseases
by: Karolina Dudziak, et al.
Published: (2022-09-01)

Xenotransplantation of Human glioblastoma in Zebrafish larvae: in vivo imaging and proliferation assessment
by: Luis A. Vargas-Patron, et al.
Published: (2019-05-01)

Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction
by: Henry Blanton, et al.
Published: (2022-12-01)

Electrically Polarized Withaferin A and Alginate-Incorporated Biphasic Calcium Phosphate Microspheres Exhibit Osteogenicity and Antibacterial Activity In Vitro
by: Itishree Priyadarshini, et al.
Published: (2022-12-01)

Systematic Roadmap for Cancer Drug Screening Using Zebrafish Embryo Xenograft Cancer Models: Melanoma Cell Line as a Case Study
by: Patricia Letrado, et al.
Published: (2021-07-01)

Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model
by: Ching-Te Kuo, et al.
Published: (2021-12-01)

An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation
by: Chiara Tobia, et al.
Published: (2021-12-01)

Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells
by: Lanpeng Chen, et al.
Published: (2020-03-01)

Improving zebrafish embryo xenotransplantation conditions by increasing incubation temperature and establishing a proliferation index with ZFtool
by: Pablo Cabezas-Sainz, et al.
Published: (2018-01-01)